Jaikirshan Khatri, MD
Interventional Cardiology · New York, NYNPI 1528037165
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Boston Scientific at 41.1% of the total. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 573 payments — averaging $535.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$126K
- Medtronic$44K
- Shockwave Medical, Inc$37K
- Abbott$28K
- Terumo Medical Corporation$27K
- Asahi Intecc CO., LTD.$13K
- plus $31K from 22 others
Across 39 payments — averaging $14,922 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$475K
- Magenta Medical Inc$34K
- Cardiovascular Systems Inc.$29K
- Medtronic$26K
- Neovasc Medical Inc$17K
- Asahi Intecc USA, Inc.$1K
What the payments were for
- Consulting fees$91,23230%
- Speaking & faculty fees$148,81048%
- Travel & lodging$42,64814%
- Food & beverage$23,0928%
- Education$1,1770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 153 | $126,265 |
| Medtronic(2 entities) | 108 | $43,629 |
| Shockwave Medical, Inc | 31 | $37,392 |
| Abbott | 84 | $28,340 |
| Terumo Medical Corporation | 50 | $27,114 |
| Asahi Intecc CO., LTD. | 2 | $13,286 |
| Biotronik Inc. | 15 | $8,808 |
| Siemens Medical Solutions USA, Inc. | 14 | $5,896 |
| Abiomed | 19 | $4,384 |
| Asahi Intecc USA, Inc. | 28 | $3,421 |
| Philips North America LLC | 8 | $1,618 |
| Teleflex LLC | 4 | $1,543 |
| Cardiovascular Systems Inc. | 23 | $1,455 |
| Corindus Inc. | 11 | $1,441 |
| Spectrawave, Inc | 4 | $546 |
| Silk Road Medical, Inc. | 1 | $350 |
| Atricure, Inc. | 2 | $247 |
| Verge Medical, Inc. | 2 | $222 |
| Edwards Lifesciences | 1 | $202 |
| Seagen Inc. | 2 | $175 |
| Neovasc Medical Inc | 2 | $171 |
| Bolton Medical Inc | 2 | $129 |
| EKOS Corporation | 1 | $93 |
| Teleflex Medical Canada Inc. | 1 | $86 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $70 |
| Penumbra, Inc. | 1 | $37 |
| Canon Medical Systems USA, Inc. | 1 | $24 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL VASCULAR ACCESS$42,976
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$32,785
- ONYX FRONTIER$22,129
- RESOLUTE ONYX$18,878
- GlideWire$14,817
- METACROSS OTW$14,753
- CROSSLEAD$12,965
- Dragonfly OCT$12,000
- GENERAL - THERAPIES$11,273
- HI-TORQUE BALANCE$9,025
- GLIDESHEATH SLENDER$8,596
- TR Band$7,600
- Heartrail$6,600
- Optitorque$5,200
- AVVIGO Guidance System$4,739
- Impella$4,221
- Vascular Lithotripsy$4,136
- SUPERA$2,750
- Glidesheath$2,200
- ASAHI PTCA Guide Wire$2,000
How this compares
$306,960 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 80 | $75,009 |
| JardianceEmpagliflozin | 46 | $57,424 |
| Repatha SureclickEvolocumab | 57 | $39,096 |
| BrilintaTicagrelor | 50 | $34,364 |
| EntrestoSacubitril/Valsartan | 14 | $15,550 |
| XareltoRivaroxaban | 21 | $14,584 |
| Praluent PenAlirocumab | 19 | $13,844 |
| Ranolazine ErRanolazine | 70 | $5,915 |
| Rosuvastatin Calcium | 251 | $4,356 |
| ClopidogrelClopidogrel Bisulfate | 305 | $3,814 |
| Metoprolol Succinate | 170 | $2,352 |
| Atorvastatin Calcium | 197 | $2,048 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 131 | $1,935 |
| Valsartan | 22 | $1,248 |
| Spironolactone-HctzSpironolact/Hydrochlorothiazid | 34 | $994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $75,00980 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 382 interventional cardiology providers in New York.
Other interventional cardiology in New York
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- Prakash KrishnanNew York$387K
- Samin SharmaNew York$291K
- Torsten VahlNew York$280K
- George DangasNew York$263K
- Jeffrey MosesNew York$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.